Leadership Overview
CenExel Clinical Research has 10 executives leading key functions including strategy, operations, finance, human resources, and medical research.
Focused on delivering premium data and operational excellence, CenExel Clinical Research drives successful clinical trial outcomes through a nationwide network of Centers of Excellence that prioritize patient engagement and scientific precision.
Focused on delivering premium data and operational excellence, CenExel Clinical Research drives successful clinical trial outcomes through a nationwide network of Centers of Excellence that prioritize patient engagement and scientific precision.
Leadership Roles at CenExel Clinical Research
Sy Pretorius - Chief Executive Officer
Sy Pretorius, the Chief Executive Officer at CenExel Clinical Research, directs the overarching strategic vision for the nationwide network of clinical research sites. Overseeing the integration of 18 Centers of Excellence, the Chief Executive Officer ensures alignment between scientific expertise and the complex requirements of global Pharma and Biotech partners. This leadership role involves scaling operational efficiencies to maintain high-quality data standards across all metropolitan locations. By fostering a culture of innovation, Sy Pretorius drives the organization toward superior clinical trial outcomes. The Chief Executive Officer manages high-level relationships with industry stakeholders to expand the footprint of the company. Through rigorous oversight of corporate performance, Pretorius secures the long-term growth and market competitiveness of the entire research network, ensuring that every site delivers consistent, real-world solutions for modern medical development.
Todd Orullian - Chief Financial Officer
Todd Orullian, the Chief Financial Officer at CenExel Clinical Research, governs the fiscal health and capital allocation strategies of the organization. Overseeing financial planning and analysis, the Chief Financial Officer ensures that the network maintains the necessary resources to support 18 Centers of Excellence. This leadership role involves managing complex budgeting processes that align with the long-term growth objectives of the company. By evaluating investment opportunities in new research technologies, Todd Orullian strengthens the competitive position of the firm. The Chief Financial Officer collaborates with executive leadership to assess the financial impact of various clinical trial portfolios. Through meticulous oversight of revenue cycles and cost management, Orullian provides the stability required for sustained expansion. This financial stewardship enables the company to continue delivering premium data and scientific expertise to the global pharmaceutical industry.
Bethany Sensenig - Chief Financial Officer & Head of Strategy
Bethany Sensenig, the Chief Financial Officer & Head of Strategy at CenExel Clinical Research, architects the long-term growth roadmap and financial framework for the organization. Focusing on market expansion, the Chief Financial Officer & Head of Strategy identifies strategic opportunities to increase the footprint of the network. This role involves analyzing industry trends to ensure that the company remains at the forefront of clinical research innovation. By integrating financial planning with strategic initiatives, Bethany Sensenig drives the development of new service offerings. The Chief Financial Officer & Head of Strategy collaborates with the Board to secure the resources necessary for scaling operations. Through rigorous market analysis, Sensenig ensures that the company maintains a competitive edge in the global Pharma and Biotech sectors. This leadership role provides the vision required to sustain the commitment to real-world solutions.
Daniel Coyle - Chief Operating Officer
Daniel Coyle, the Chief Operating Officer at CenExel Clinical Research, manages the daily execution of clinical trial protocols across the national site network. Focusing on internal scaling, the Chief Operating Officer optimizes workflows to enhance patient recruitment and data collection speed. This role requires constant coordination with site directors to ensure adherence to strict regulatory standards and quality benchmarks. By streamlining administrative processes, Coyle improves the overall throughput of complex trials. Daniel Coyle monitors operational metrics to identify bottlenecks and implement corrective measures that boost site productivity. The Chief Operating Officer maintains a focus on resource allocation to support the diverse needs of Biotech clients. Through systematic management of site-level operations, Coyle ensures that the network remains a preferred partner for results-driven clinical research organizations seeking reliable, high-quality data delivery.
Sarah Kazmi - Chief Operating Officer, Cenexel (Hollywood)
Sarah Kazmi, the Chief Operating Officer, Cenexel (Hollywood) at CenExel Clinical Research, manages the specialized operational requirements of the Hollywood site. Focusing on supply chain logistics and site-specific trial management, the Chief Operating Officer, Cenexel (Hollywood) ensures that local operations meet the rigorous data standards of the broader network. This role involves coordinating with regional partners to optimize the delivery of real-world solutions. By refining site-level processes, Sarah Kazmi enhances the efficiency of complex clinical trials conducted within the metropolitan area. The Chief Operating Officer, Cenexel (Hollywood) monitors local performance metrics to ensure alignment with the national strategy. Through dedicated oversight of site resources, Kazmi supports the overall mission of the company. This leadership role remains essential for maintaining the high-quality patient engagement and scientific precision that characterize the reputation of the organization.
Thomas Shiovitz - Founder & President
Thomas Shiovitz, the Founder & President at CenExel Clinical Research, provides the foundational vision and leadership that guide the organization. Overseeing the long-term mission of the network, the Founder & President ensures that the commitment to scientific excellence remains central to all operations. This role involves mentoring the executive team and maintaining relationships with key industry stakeholders. By championing the importance of patient engagement, Thomas Shiovitz drives the culture of the company. The Founder & President monitors the evolution of the clinical research landscape to ensure that the network adapts to new challenges. Through strategic guidance, Shiovitz supports the growth of the 18 Centers of Excellence. This leadership role is essential for preserving the legacy of the organization while pushing the boundaries of what is possible in modern clinical trial outcomes.
Erin Monteverdi - Chief of Staff
Erin Monteverdi, the Chief of Staff at CenExel Clinical Research, coordinates cross-functional initiatives to ensure seamless communication between the executive team and site operations. Facilitating strategic projects, the Chief of Staff aligns internal resources with the mission of delivering exceptional patient engagement. This role involves managing high-priority tasks that support the growth of the nationwide network. By streamlining decision-making processes, Erin Monteverdi enhances the agility of the leadership team. The Chief of Staff monitors the progress of key organizational goals to ensure that all departments remain focused on the core objectives of the company. Through effective project management and stakeholder engagement, Monteverdi drives operational cohesion across the 18 Centers of Excellence. This leadership role remains vital for maintaining the high standards of scientific expertise and data quality that define the reputation of the organization.
Kristine Meade - Chief Human Resources Officer
Kristine Meade, the Chief Human Resources Officer at CenExel Clinical Research, directs the talent acquisition and workforce development strategies for the entire network. Overseeing the recruitment of top-tier scientific and clinical staff, the Chief Human Resources Officer ensures that each Center of Excellence possesses the expertise required for complex trials. This role involves building a culture of excellence that prioritizes patient engagement and professional growth. By implementing comprehensive training programs, Kristine Meade maintains high standards of performance across all metropolitan locations. The Chief Human Resources Officer manages organizational design to support the evolving needs of the clinical research industry. Through strategic workforce planning, Meade ensures that the company retains the talent necessary to drive successful trial outcomes. This leadership role directly impacts the ability of the organization to provide consistent, high-quality service to global Pharma and Biotech partners.
Kyle Coupe - Chief Medical Officer
Kyle Coupe, the Chief Medical Officer at CenExel Clinical Research, oversees the scientific integrity and medical standards across the nationwide network. Directing the clinical oversight of complex trials, the Chief Medical Officer ensures that all research activities adhere to the highest ethical and safety protocols. This role involves providing expert guidance to site investigators to maintain premium data quality. By fostering collaboration between medical teams, Kyle Coupe enhances the scientific expertise available to Biotech and Pharma partners. The Chief Medical Officer monitors emerging medical technologies to keep the organization at the cutting edge of clinical research. Through rigorous review of trial protocols, Coupe ensures that the company delivers reliable outcomes for every project. This leadership role remains critical for maintaining the trust of the global research community and the success of the clinical trials.
Todd Bertoch - Chief Medical Officer, Pain
Todd Bertoch, the Chief Medical Officer, Pain at CenExel Clinical Research, directs the specialized research initiatives focused on pain management trials. Overseeing the medical protocols for this specific therapeutic area, the Chief Medical Officer, Pain ensures that all studies meet the highest standards of scientific rigor. This role involves working closely with site investigators to optimize patient outcomes and data accuracy. By leveraging deep expertise in pain research, Todd Bertoch enhances the capabilities of the network to handle complex clinical trials. The Chief Medical Officer, Pain collaborates with other medical leaders to share best practices across the organization. Through meticulous oversight of trial execution, Bertoch ensures that the company provides valuable insights to Pharma and Biotech clients. This leadership role remains vital for maintaining the reputation of the firm as a leader in specialized clinical research.
Explore Leadership Teams in Business Services
INL is one of the U.S. Department of Energy's (DOE's) national laboratories. The laboratory performs work in each of DOE's strategic goal areas: energy, national security, science and environment. INL is the nation's center for nuclear energy research and development. The company is based in Idaho Falls, Idaho.
Company Leadership AR
BF
Founded in 2002 and headquartered in Piscataway, New Jersey, Genscript is the worlds leading biotech company providing life sciences services and products. The company has four platforms including leading life-science services and products platform to provide one-stop solutions to global research communities, a biologics contract development and manufacturing organization (the "CDMO") platform, an industrial synthetic products platform, and an integrated global cell therapy platform.
Company Leadership PL
SW
LW
Caris was founded in 2008 with a simple but powerful purpose to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of data, we are trailblazing the path to precision medicine by providing physicians and patients with the highest quality information about disease.
Company Leadership ST
VD
CF
OFFICIAL PAGE - Renault Nissan Technology & Business Centre India (RNTBCI) is a captive automotive technology and business centre supporting Renault & Nissan globally. Established in 2007, it is located in Mahindra World City, Chennai, India, and the company's satellite offices are there in Hyderabad and Bengaluru. RNTBCI was bestowed with the ISO 9001:2015 certification in 2019 and ISO/IEC 27001:2013 certification in 2020 and is also now a Google Cloud Partner. RNTBCI contributes to Technology requirements with dedicated teams for Product Engineering: Vehicle and Components, Chassis, Powertrain, Embedded Software, Electrical and Electronic, Customer Performance, CAE and Test; Process Engineering: BIW, Trims, Stamping, Powertrain; Research and advanced Engineering: System Development, Battery Research, Social Research, and Creative Lab. RNTBCI has After-Sales Engineering, in-house Styling, and Test Capabilities for Multi-media/ EE Systems, Test Tracks, Test Chambers, and partnerships with various test agencies. RNTBCI also contributes to Business requirements in areas of IS/IT; APO; ACO and Global Shared Services (Finance, HR, GTC). As RNTBCI is serving both Renault and Nissan many of the Alliance practices are embodied in the company's way of working. RNTBCI is proud to be recognized by some of the important and influential organizations around the world. RNTBCI was felicitated as the ‘Best Employer of Tamil Nadu’ at the Tamil Nadu Best Employer Brand Awards 2022. For the fifth consecutive time, RNTBCI has been listed in the Top 100 Best Companies for Working Women by BCWI Study in 2022. RNTBCI has been commended time and again for CSR initiatives. The Indo-French Chamber of Commerce and Industry lauded RNTBCI’s CSR measures in 2021 and 2022. The Greater Chennai Corporation acknowledged and felicitated RNTBCI for CSR projects and support extended to the community during the COVID-19 pandemic.
Company Leadership CC
ST
PN
EA
Frequently Asked Questions Regarding CenExel Clinical Research Top Executives and Leadership Team
Unlock more people and company data
